California Newborn Screening Program
In California, about 1 out of every 600 babies tested will have a rare, but treatable genetic disorder. To ensure the health of all its newborns,
state law requires that all babies born in California have newborn screening soon after birth.
Please join the
California Newborn Screening Program and Provider Responsibilities webinar on Thursday, November 2, 2023, from 5:00–6:00 PM. This webinar will present an overview of the California Newborn Screening Program process, its importance for infant health, key benefits and the vital role of the provider. Advanced registration is required.
Continuing Medical Education (CME) credits will be offered. The Genetic Disease Screening Program designates this webinar/ live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Each physician should claim only the credit commensurate with the extent of their participation in the activity. The Genetic Disease Screening Program is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
The California Newborn Screening (NBS) Program is a public health program that screens all babies for many serious but treatable genetic disorders. Newborn screening began in California in 1966 with screening for one disorder, called phenylketonuria (PKU). The NBS Program has expanded and now includes 80 different disorders, both genetic (passed down in families) and congenital (present at birth).
The goal of the program is to identify babies with these disorders early, so that treatment can be started right away. A parent or guardian of the newborn child may only decline newborn screening based on the objection that it conflicts with his or her religious beliefs or practices.
How it works
The NBS Program takes a blood sample from a newborn’s heel from 12 to 48 hours after birth to check for genetic disorders. At the same time, the newborn receives a hearing and congenital heart disease screening. The
California Newborn Hearing Screening Program helps identify hearing loss in infants and guide families to the appropriate services needed to develop communication skills. The California Congenital Health Disease Screening Program, can be reached by email.
Parent who want their baby’s blood spot destroyed after newborn screening can
contact the NBS Program and request this.
Cost and billing
Medi-Cal and most other insurance companies cover the NBS Program about 99% of the time.
If your baby was born in a hospital and a blood sample was taken there, the cost is usually included in the hospital bill. If your baby was born at home, you will receive a notice from the NBS Program asking for insurance information. As a courtesy, CDPH will bill your insurance for you.